Grandeur Peak Global Advisors, LLC Exact Sciences Corp Transaction History

Grandeur Peak Global Advisors, LLC

  • $1.13 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 17, 2022
SELL
$31.97 - $49.37 $1.27 Million - $1.96 Million
-39,640 Reduced 40.26%
58,820 $1.91 Million
Q2 2022

Aug 15, 2022
BUY
$35.61 - $76.23 $295,669 - $632,937
8,303 Added 9.21%
98,460 $3.88 Million
Q1 2022

May 13, 2022
BUY
$57.56 - $82.54 $893,676 - $1.28 Million
15,526 Added 20.8%
90,157 $6.3 Million
Q4 2021

Feb 15, 2022
BUY
$72.5 - $100.68 $493,217 - $684,926
6,803 Added 10.03%
74,631 $5.81 Million
Q3 2021

Nov 16, 2021
BUY
$90.24 - $124.05 $1.42 Million - $1.95 Million
15,695 Added 30.11%
67,828 $6.47 Million
Q2 2021

Aug 17, 2021
BUY
$93.66 - $139.27 $1.83 Million - $2.72 Million
19,500 Added 59.76%
52,133 $6.48 Million
Q1 2021

May 18, 2021
BUY
$116.57 - $155.01 $1.02 Million - $1.36 Million
8,750 Added 36.64%
32,633 $4.3 Million
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $214,161 - $305,558
2,150 Added 9.89%
23,883 $3.16 Million
Q3 2020

Nov 17, 2020
BUY
$72.92 - $102.01 $1.21 Million - $1.69 Million
16,608 Added 324.06%
21,733 $2.22 Million
Q2 2020

Aug 13, 2020
BUY
$55.75 - $92.75 $268,993 - $447,518
4,825 Added 1608.33%
5,125 $446,000
Q1 2020

May 18, 2020
BUY
$37.9 - $104.44 $11,370 - $31,332
300 New
300 $17,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email